Vétoquinol: A controlled growth launch

The Challenge

Vétoquinol, an international veterinary pharmaceutical company of French origin, was not present on Amazon despite strong demand for its products.

The launch had to be carried out within an extremely rigorous framework, with high compliance and drug safety monitoring requirements comparable to Health Canada and FDA standards.

With around 50 SKUs and a complex regulatory environment, every step had to be validated and executed with precision. Speed of execution was also a key challenge in order to quickly capture existing demand.

The Objectives

The objective was to launch the brand effectively on Amazon and achieve rapid growth, with a clear target of $2.5 million within two years.

It was also a matter of building a compliant, stable and scalable presence capable of supporting new customer acquisition while adhering to the industry’s regulatory requirements.

The ProMerit Approach

ProMerit implemented a phased, structured approach, supported by a clear and approved action plan, enabling a balance between speed of execution and regulatory rigour.

ProMerit also supported Vétoquinol in implementing a drug safety monitoring system tailored to the Amazon environment, including the management of reports, monitoring mechanisms and the required response protocols. In this context, a strict compliance management framework was established from the outset, ensuring compliance with veterinary product requirements throughout the roll-out.

This structure ensured consumer safety, the ongoing compliance of the product catalogue and the sustainability of operations on the platform.

In parallel, a performance-driven marketing strategy was rolled out to capture existing demand, build the brand’s presence and maximize customer retention, notably through the implementation of the Subscribe & Save program.

Execution and results

● Gradual roll-out of the product catalogue (≈ 50 SKUs)
● Structuring of product listings in accordance with regulatory requirements
● Implementation of Amazon’s drug safety monitoring system
● Set-up of the Subscribe & Save program
● Optimization of product listings and positioning
● Roll-out of targeted acquisition campaigns
● Rigorous management of compliance and validation processes

n less than two years, Vétoquinol went from $0 to $2.5 million in revenue on Amazon, confirming the strength of the launch strategy and rapid execution.

The implementation of the Subscribe & Save program has generated a base of recurring revenue, while supporting customer loyalty.

The brand also recorded strong growth in the number of orders, reflecting rapid new customer acquisition in a highly regulated environment.